Inventor · disambiguated record
Fengzhi Li
Also filed as: LI FENGZHI
8 granted patents·4 pending applications·10 citations·filing 2004–2025
78Inventor score
Files withCANGET BIOTEKPHARMA LLC4HEALTH RESEARCH INC4CANGET BIO TEKPHARMA LLC1CANGET BIOTEKPHARMA1LI FENGZHI1
Top patents by PatentIndex Score
12 records- 0182US7569221B2Compositions and methods for identifying agents that alter expression of survivinHEALTH RESEARCH INC·Filed 2007·Granted Aug 4, 2009·4 cites·6 claims
- 0279US11084828B2Use of the FL118 core chemical structure platform to generate FL118 derivatives for treatment of human diseaseCANGET BIOTEKPHARMA LLC·Filed 2019·Granted Aug 10, 2021·1 cites·12 claims
- 0377US7968708B2Azepans and methods for making and using sameUNIV NEW YORK STATE RES FOUND·Filed 2007·Granted Jun 28, 2011·3 cites·8 claims
- 0465US8043815B2Methods for analysis of PDEF and survivin as interconnected cancer biomarkers and targets for personalized medicineHEALTH RESEARCH INC·Filed 2008·Granted Oct 25, 2011·1 cites·8 claims
- 0564US2025092058A1Matter of composition, synthesis, formulation and application of fl 118 platform positions 7 and 9-derived analogues for treatment of human diseaseCANGET BIOTEKPHARMA LLC·Filed 2024·Application pending·0 cites
- 0661US10344037B2Use of the FL-one hundred eighteen core chemical structure platform to generate FL-one hundred eighteen derivatives for treatment of human diseaseCANGET BIO TEKPHARMA LLC·Filed 2015·Granted Jul 9, 2019·1 cites·12 claims
- 0760US2007248692A1Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agentsHEALTH RESEARCH INC·Filed 2007·Application pending·0 cites
- 0857US2005250854A1Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agentsHEALTH RESEARCH INC·Filed 2004·Application pending·0 cites
- 0949US12187735B2Matter of composition, synthesis, formulation and application of FL118 platform positions 7 and 9-derived analogues for treatment of human diseaseCANGET BIOTEKPHARMA LLC·Filed 2020·Granted Jan 7, 2025·0 cites·14 claims
- 1045US2025312469A1FL118 COMPLEXES FOR TARGETING DDX5, UbE2T or USP2aCANGET BIOTEKPHARMA·Filed 2025·Application pending·0 cites
- 1144US12268682B2Anticancer drug FL118 formulation for treatment of human cancerCANGET BIOTEKPHARMA LLC·Filed 2020·Granted Apr 8, 2025·0 cites·15 claims
- 1231US9422303B2Formulations of water-insoluble chemical compounds and methods of using a formulation of compound FL118 for cancer therapyLI FENGZHI·Filed 2011·Granted Aug 23, 2016·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Fengzhi Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →